A total of 105 institutions have reported a stake in SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 8,467,400 | 1,627,495 | 23.79% | $31,922,098.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 7,541,054 | 1,854,168 | 32.60% | $28,429,774.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 3,077,337 | 812,953 | 35.90% | $11,604,041.00 |
| STATE STREET CORP | 31 Dec, 2025 | 2,188,171 | 827,257 | 60.79% | $8,249,405.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 1,387,849 | 1,073,147 | 341.00% | $5,232,191.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 1,340,668 | -1,017,331 | -43.14% | $5,054,320.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,082,207 | 936,351 | 641.97% | $4,079,920.00 |
| Nuveen, LLC | 31 Dec, 2025 | 1,023,961 | 26,051 | 2.61% | $3,860,333.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 930,750 | 199,575 | 27.30% | $3,508,927.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 890,929 | -163,862 | -15.54% | $3,358,802.00 |
| DAGCO, INC. | 31 Dec, 2025 | 577,540 | 577,540 | 0.00% | $2,177,326.00 |
| BARCLAYS PLC | 31 Dec, 2025 | 511,034 | 328,354 | 179.74% | $1,926,599.00 |
| Clear Street Group Inc. | 31 Dec, 2025 | 500,000 | 500,000 | 0.00% | $1,885,000.00 |
| Everhart Financial Group, Inc. | 31 Dec, 2025 | 466,216 | 135,066 | 40.79% | $1,757,634.00 |
| JONES FINANCIAL COMPANIES LLLP | 31 Dec, 2025 | 429,243 | 428,869 | 114,670.86% | $1,618,246.00 |
| DIADEMA PARTNERS LP | 31 Dec, 2025 | 424,900 | 24,900 | 6.23% | $1,601,873.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 411,654 | 392,389 | 2,036.80% | $1,551,936.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 408,401 | 114,295 | 38.86% | $1,539,672.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 349,755 | -513,820 | -59.50% | $1,318,577.00 |
| GSA CAPITAL PARTNERS LLP | 31 Dec, 2025 | 345,052 | -173,943 | -33.52% | $1,301.00 |